Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial
Author:
Funder
Henry R Shibata Fellowship
Sanofi-Aventis Canada
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/23/6/1512/401423/mdr465.pdf
Reference34 articles.
1. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study;Siewert;Ann Surg,1998
2. Two thousand transhiatal esophagectomies: changing trends, lessons learned;Orringer;Ann Surg,2007
3. Treatment outcomes of resected esophageal cancer;Hofstetter;Ann Surg,2002
4. Extended lymph-node dissection for gastric cancer;Bonenkamp;N Engl J Med,1999
5. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction;Macdonald;N Engl J Med,2001
Cited by 90 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Docetaxel-Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15-Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network;Annals of Surgical Oncology;2023-12-23
2. A phase 2 trial of peri-operative avelumab and chemotherapy for locally advanced gastro-esophageal adenocarcinoma: Association of AGR2/AP-1 complex CD8 T-cells and M2-Tumour Associated Macrophages with treatment response;2023-12-15
3. Chemotherapy is the preferred neoadjuvant treatment of oesophageal adenocarcinoma;British Journal of Surgery;2023-10-05
4. NESC Multicenter Phase II Trial in the Preoperative Treatment of Gastric Adenocarcinoma with Chemotherapy (Docetaxel-Cisplatin-5FU + Lenograstim) Followed by Chemoradiation (CRT) Based 5FU and Oxaliplatin and Surgery;Cancer Research and Treatment;2023-10-05
5. The Evolution of Neo-Adjuvant Therapy in the Treatment of Oesophageal and Gastro-Oesophageal Junction Adenocarcinomas;Cancers;2023-09-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3